United Kingdom· GB-APID-23306311000001109
Levothyroxine sodium 25micrograms/5ml oral solution sugar free
A levothyroxine sodium product containing levothyroxine, registered in United Kingdom by Advanz Pharma. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Levothyroxine sodium is registered in 15 of 19 countries.
Countries holding a registration under ATC H03AA01 (levothyroxine sodium), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Levothyroxine sodium · ATC H03AA01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of levothyroxine sodium costs, country by country.
Normalised to the WHO defined daily dose (0.15 mg), the median price runs from $0.12 in Italy to $0.29 in Switzerland — a ×2.4 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Levothyroxine sodium · price per daily dose (0.15 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.29
- IT Italy$0.12
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Levothyroxine
- Manufacturer
- Advanz Pharma
- Country
- United Kingdom (GB)
- ATC code
- H03AA01
- ATC class
- Levothyroxine sodium
- Defined daily dose
- 0.15 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5021691019107
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
883 interactions on record for levothyroxine sodium.
Graded by severity as the source publishes them — 184 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Levothyroxine sodium · interactions on record
883 records
- 184 moderate
- 22 minor
- 578 info
Most severe, free to view
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
99 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under H03AA01
Levothyroxine sodium, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9d9bc69-9ed1-494a-8a59-11afe9efca17 GET /v1/drugs/b9d9bc69-9ed1-494a-8a59-11afe9efca17?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "23306311000001109",
"desc": "Levothyroxine sodium 25micrograms/5ml oral solution sugar free (Advanz Pharma)",
"form": "Oral solution",
"vpid": "10749711000001108",
"source": "dmd",
"vtm_id": "776526008",
"strength": "5 microgram",
"substance": "Levothyroxine",
"ingredient": "Levothyroxine sodium anhydrous",
"supplier_code": "24129411000001106"
}See everything about levothyroxine sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.